搜尋結果
Annexon's neurological disorder drug meets main goal of late-stage study
Reuters· 10 小時前Annexon Inc said on Tuesday its experimental drug to treat a rare neurological disorder met the main goal of a late-stage trial.
FDA panel to review psychedelic drug MDMA for first time
Reuters· 10 小時前A panel of advisers to the U.S. Food and Drug Administration will meet on Tuesday to discuss a ...
How conservationists improve lives of humans and animals
South China Morning Post· 2 小時前Krithi Karanth, a conservation scientist and educator, who grew up in Karnataka, India, began ...
Testimony to begin in Hunter Biden's criminal trial, with focus on phone messages
Reuters· 11 小時前Hunter Biden's criminal trial on gun charges will begin in earnest on Tuesday with opening ...
Why isn’t Jameela Jamil afraid of cancel culture?
South China Morning Post· 23 小時前... recently opened up to Kelly Ripa about her previous struggles with an eating disorder, say ...
Council Post: From Awareness To Action: Building A Neurodiverse And Inclusive Workplace
Forbes· 16 小時前Kyle Samuels is the founder & CEO of Creative Talent Endeavors (CTE) and an iconoclast in the ...
Forbes EQ BrandVoice: A New Era Of Wellbeing: A Comprehensive Public Health Approach To ...
Forbes· 16 小時前The mental health of employees shapes the core of organizational success. Initiatives represent ...
Y Combinator Startups That Could Be The Next Tech Unicorns
Forbes· 16 小時前Y Combinator is an eminent startup accelerator and venture capital firm that provides intensive ...
Generative AI Becomes A Patient-Referral Advisor Steering People Toward Mental Health Therapy
Forbes· 16 小時前In today’s column, I am continuing my ongoing series about the impact of generative AI in the ...
Virtual signaling
China Daily· 18 小時前As the Joe Biden administration pushes ahead with its "Indo-Pacific" strategy, greater weight has been given to the Quad ...